Tranxene

Tranxene is a brand name of clorazepate, approved by the FDA in the following formulation(s):

TRANXENE (clorazepate dipotassium - tablet; oral)

• 
  Manufacturer: LUNDBECK INC
  
  Approved Prior to Jan 1, 1982
  
  Strength(s): 15MG ^[RLD][AB], 3.75MG ^[AB], 7.5MG ^[AB]

Has a generic version of Tranxene been approved?

Yes. The following products are equivalent to Tranxene:

clorazepate dipotassium tablet; oral

• 
  Manufacturer: MYLAN
  
  Approval date: July 17, 1987
  
  Strength(s): 15MG ^[AB], 3.75MG ^[AB], 7.5MG ^[AB]


• 
  Manufacturer: RANBAXY
  
  Approval date: September 29, 2004
  
  Strength(s): 15MG ^[AB], 3.75MG ^[AB], 7.5MG ^[AB]


• 
  Manufacturer: TARO
  
  Approval date: April 27, 2000
  
  Strength(s): 15MG ^[AB], 3.75MG ^[AB], 7.5MG ^[AB]


• 
  Manufacturer: WATSON LABS
  
  Approval date: February 9, 1988
  
  Strength(s): 15MG ^[AB], 3.75MG ^[AB], 7.5MG ^[AB]

GEN-XENE (clorazepate dipotassium tablet; oral)

• 
  Manufacturer: ALRA
  
  Approval date: April 26, 1988
  
  Strength(s): 15MG ^[AB], 3.75MG ^[AB], 7.5MG ^[AB]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Tranxene. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with Tranxene.

See also...

• Tranxene Advanced Consumer Information (Micromedex)
• Clorazepate Consumer Information (Wolters Kluwer)
• Clorazepate Sustained-Release Tablets Consumer Information (Wolters Kluwer)
• Clorazepate Consumer Information (Cerner Multum)
• Gen-Xene Advanced Consumer Information (Micromedex)
• Clorazepate Advanced Consumer Information (Micromedex)
• Clorazepate Dipotassium AHFS DI Monographs (ASHP)